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Background: Bone substation grafts, such as hydroxyapatite (HA) and
tricalciumphosphate (TCP), have been extensively used in clinical applications, but
evidence suggests that they offer poor osteoinductive properties compared to
allografts and autografts. In order to increase bone growth with such grafts, Bone
Morphogenetic Protein 2 (BMP-2) was incorporated into a three dimensional reservoir.
The purpose of the present study was to develop a novel drug delivery system which is
capable of controlled release of BMP-2.
Methods: DBB were prepared from bovine cancellous bone harvested from fetal bovine
femur or tibia and then sinting at 1000°C. BMP-2-loaded chitosan (CS) microspheres were
fabricated by cross-linking. Then the treated DBB powders were blended with chitosan
microspheres solution. Finally, the composites were lyophilized with a freeze dryer to
obtain the DBB/CMs scaffolds. X-ray diffractor (XRD), scanning electron microscopy (SEM)
and Fourier transform infrared (FT-IR) were used to characterize the sample. The
quantification of the delivery profile of BMP-2 was determined using an enzyme-linked
immunosorbent assay (ELISA) kit. The in vitro assays were to characterize the
biocompatibility of this composite.
Results: In this study, BMP-2/Chitosan (CS) microspheres were successively loaded onto a
deproteinized bovine bone (DBB) scaffold. The release profile of BMP-2 indicated an initial
burst release followed by a more even sustained release. An in vitro bioactivity assay
revealed that the encapsulated growth factor was biologically active.
Conclusions: The cell culture assay suggest that the excellent biocompatibility of the
DBB- BMP-2/CS. Therefore, this novel microsphere scaffold system can be effectively used
in current tissue engineering applications.
Keywords: Deproteinized bovine bone (DBB), Scaffold, Microsphere, Drug delivery
systemBackground
An increasing number of patients suffer from bone defects that require transplantation
[1]. However, bone grafting, the gold standard in bone defect management, bears consid-
erable risks; donor site pain and morbidity, infection, increased blood loss, and longer op-
erating times [2-4]. The most common alternative is to use human cadaveric bone
(allograft), which has additional disadvantages, including rejection, limited supply, and
potential disease transmission. Interest has thus focused on animal bone (xenograft) that© 2015 Li et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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complications with immunogenicity and disease transmission also hinder the effectiveness
of this method [5].
For an ideal bone tissue engineering scaffold, one of the most important criteria is that
the scaffold consists of a highly interconnected porous network with pore sizes large enough
for cell migration, fluid exchange, and eventually tissue ingrowth and vascularization. Al-
though synthetic calcium phosphate ceramics (such as β-tricalciumphosphate (β-TCP) [6],
and hydroxyapatite (HA) [7]) with their excellent biocompatibility are designed to mimic
the native extracellular matrix as closely as possible [8], the porous network of the artificial
bone scaffold still cannot compare to natural bone in terms of structure and function.
There is a growing need to provide alternatives to traditional bone grafting. Deprotei-
nized bovine bone (DBB) [9] manufactured from natural materials, such as coral or nat-
ural bone, has the advantage of inheriting the properties of the raw source materials,
including the pore structure. Because all organic material is removed by stepwise an-
nealing (up to 300°C), there is no need for concern with immunogenicity or disease
transmission. Therefore, this kind of inorganic porous bone has gained wide acceptance
for various dental and medical applications; e.g. fillers for periodontal defects, alveolar
ridge augmentation, maxillofacial reconstruction, dental implants and spine fusion.
DBB has been widely used in dentistry as an alternative to autologous bone grafts. Al-
though DBB provides an osteoconductive scaffold, it is not capable of enhancing bone
regeneration because it is not osteoinductive.
In addition, during the bone healing process, the constant remodeling activities are
coordinated and controlled by various growth factors, such as TGF-β, PDGF, FGF-2,
and BMPs [10]. The osteoinductive capacity of bone morphogenetic proteins (BMPs),
especially BMP-2, have been proven to promote osteogenic differentiation [11]. BMP-2
is now approved by the U.S. Food and Drug Administration (FDA) for restricted clin-
ical use in open tibial fractures and anterior spinal fusion. In order to render DBB
osteoinductive, bone morphogenetic protein 2 (BMP-2) has previously been incorpo-
rated into a three dimensional reservoir (a biomimetic calcium phosphate coating) on
DBB, which effectively promoted the osteogenic response by the slow delivery of BMP-
2. Despite the proven efficacy of BMP, its clinical application is complicated by its short
biological half-life, systemic side effects and rapid clearance [12]. Delivery systems that
minimize BMP diffusion away from its therapeutic target are desirable not only for en-
hancing bone formation, but also for limiting unwanted pathologies.
In order to retain the BMPs at the site for a prolonged period of time [13], delivery
via microspheres synthesized by chitosan may be used. Chitosan has been widely used
for the controlled delivery of peptides or proteins in the form of microspheres, due to
its excellent biological properties such as biodegradability, biocompatibility, non-
toxicity, bacteriostaticity and strong adhesion [14]. The chitosan used for the synthesis
of these microspheres can be both degradable [15] as well as non-degradable [16]. In-
corporation of the molecules in these microspheres allows controlled diffusion and ex-
poses the protein molecule for a longer duration.
In this study, deproteinized bovine bone (DBB) and chitosan were chosen as carriers
for BMP-2 delivery to overcome the disadvantage of rapid clearance typically associated
with BMP-2. Firstly, chitosan microspheres (CMs) loaded with BMP-2 were prepared
by an emulsion-ionic cross-linking method. Secondly, CMs with BMP-2 was embedded
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this study was to increase the efficiency of this microsphere-scaffold as a carrier for
growth factors and to estimate the osteogenic effect of this microsphere-scaffold as a
potential candidate for bone tissue engineering.Materials and methods
Preparation of the DBB scaffold
Samples were prepared from bovine cancellous bone harvested from fetal bovine femur
or tibia. Using a diamond saw, the cancellous bones were sectioned into 3 mm × 3 mm×
40 mm blocks. The fatty bone marrow was removed by immersion in 30% H2O2 for
2 h. The bone was washed with water and immersed in 1% H3PO4 for heating in a
water bath at 125°C for 2 h. The bone was washed with 95% alcohol to remove any re-
sidual moisture that could cause small cracks during heat treatment. Following air dry-
ing for at least 12 h, the bone underwent heat treatment in a furnace (Siliconit muffle
furnace, Kwangsung Science Co., Korea) with a heating rate of 10°C/min up to 1000°C.
This temperature was maintained steady for 2 h under 1 atm of pressure. To obtain
constant size particles of 0.25-1 mm and 1-2 mm, a sieve with corresponding mesh size
was used. After ultrasonic cleaning and drying, the deproteinized bovine bones were
obtained.Preparation of BMP-2 loaded chitosan microspheres
BMP-2-loaded chitosan (CS) microspheres were fabricated by cross-linking. Briefly, CS
polymer with a viscosity of 150–900 cP and 75–85% deacetylation was purchased from
Sigma-Aldrich (Shanghai, China), and then refined twice by dissolving in aqueous
acetic acid solution and precipitating from dilute ammonia. The BMP-2 was also ob-
tained from Sigma-Aldrich. A CS solution (10 g/l) was prepared by dissolving CS in
2.3% (v/v) aqueous acetic acid solution. 500 mg of this CS solution and the different
contents of BMP-2 (0.75 μg/ml, 1 μg/ml, 1.25 μg/ml) were mixed and then the cross-
liker was added (vanillin 1% v/v ethanol aqueous solution). The emulsified solution was
immediately poured into the CS-BMP-2 mixture and stirred with a magnetic stirrer for
4 h so as to allow the solvent to evaporate. The hardened microspheres were then col-
lected by centrifugation at 3000 rpm for 3 min, washed three times with distilled water,
and lyophilized using a freeze dryer.Preparation of DBB/CMs scaffold
Preparation of BMP-2-loaded CS microspheres on DBB scaffold surfaces was per-
formed in the following process. In the first-step, DBB powders were radiofrequency
(RF) plasma glow-discharged (PDC-32 G, Harrick Plasma, USA) in an oxygen-filled
chamber at a pressure of 200 mTorr Pa. The plasma power density and the treatment
time were fixed at 30 W and 120 s, respectively. Then the treated DBB powders were
blended with different contents of chitosan microspheres solution and poured into a
polystyrene mold, and frozen at −20°C overnight. Finally, the composites were lyophi-
lized with a freeze dryer to obtain the DBB/CMs scaffolds.
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XRD was used to determine the structure of the synthesized DBB. XRD measurements
were performed with an X-ray diffractor [D/max-II; X-ray Diffractometer (XRD),
RIGAKU, Japan] (Cu-Ka). The samples were measured in the 2θ range from 10° to 70°
(scan speed of 0.02° per second).
The morphology of the obtained chitosan microspheres and DBB scaffolds was exam-
ined by a scanning electron microscopy (SEM, S-2400; Hitachi, Japan).
Chemical analysis of the DBB, CS and DBB/CMs materials was carried out by a Fou-
rier transform infrared (FT-IR) spectrophotometer (FTIR 650) in the range from
4000 cm−1 to 400 cm−1 at a resolution of 3 cm−1, averaging 100 scans.In vitro release profile
The quantification of the delivery profile of BMP-2 (0.75 μg/ml, 1 μg/ml, 1.25 μg/ml)
from this system was determined using an enzyme-linked immunosorbent assay
(ELISA) kit (PeproTech EC, London, UK) [17].In vitro study
Mouse calvaria-derived, pre-osteoblastic cells MC3T3-E1 were cultured as monolayers
in Alpha Minimum Essential Medium (α-MEM, GIBCO), supplemented with 10% (v/v)
fetal bovine serum (FBS; Sigma), 1% (v/v) L-glutamine (Invitrogen Corp., Carlsbad, CA,
USA), and a 1% (v/v) antibiotic and antimycotic formulation (containing penicillin G
sodium, streptomycin sulfate (Invitrogen Corp., Carlsbad, CA, USA). The medium was
changed on alternate days, and the cultures were maintained at 37°C within a humidi-
fied atmosphere containing 5% CO2.
When the confluence reached 90%, the cells were passaged (P1). After passaging
three times (P3), the cells were exposed to proliferation assays using CCK8 kits at 3d,
5d, 7d, 14d to study the impact of BMP-2 on the multiplication of MC3T3 cells. The
cells were assigned into BMP-2 groups (0.75 μg/ml, 1 μg/ml, 1.25 μg/ml) and a control
group.
Each cell suspension (5 ml) was plated at a density of 1 × 106 cells ml−1 in plates con-
taining sterile samples of microsphere-scaffolds for the cell attachment assays. SEM mi-
crographs were taken at 1 day following the initial cell co-culturing with the scaffolds.
Briefly, the co-cultured constructs were harvested, washed with PBS and then fixed
with 4% glutaraldehyde. Following 3 rinses with water, these samples were dehydrated
through a series of graded alcohol solutions and then air-dried overnight. The samples
were observed by SEM at an accelerating voltage of 30 kV (QUANTA 250 FEG, USA).Differentiation of cells on microsphere-scaffold
MC3T3-E1 cells were seeded with new medium. When the density reached 10% after 3
passages, about 1 × 106 cells were seeded on T25 flasks. Then these colonies were
switched to an osteo-inducing medium (a-MEM, 10-8 M dexamethasone, 50 μg/ml as-
corbic acid, 10 mM ß-glycerophosphoric acid). The cells were assigned into a BMP-2
group and control group respectively. Samples from each group were collected at 3d
and 7d for western blotting and real-time PCR analysis.
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MC-3 T3 cells were lysed in an RIPA buffer supplemented with protease inhibitors
(#11-10601, SinoGene Scientific, Beijing China) and phosphatase inhibitors (#11-10701,
SinoGene Scientific, Beijing China). Protein concentration was determined using the
Bradford method. 30 μg protein lysate was mixed with 2× loading buffer at 1:1 and
heated for 10 min at 95°C before being loaded for gel electrophoresis.
The proteins and protein marker (SM1881, Thermo Fermentas) were separated by
SDS-PAGE (4% stacking gel, 12% separating gel) at 120 V for 2 h. Proteins were trans-
ferred to PVDF membranes using a Bio-rad mini transfer system. The membranes were
blocked in rapid blocking Buffer (#66-11402, SinoGene) for 5 min and then probed
with primary antibodies against ALP, BMP-2, OST and RUNX2 at a dilution of 1:1000
for 2 h. After washing 3 times with PBS, at 10 min per wash, HRP-conjugated anti
rabbit and anti-mouse antibodies (10104, 10105, Miroanalysis Inc.) were applied to the
membranes at a dilution of 1:2000 for 1 h. Chemiluminescent signals were developed
using a ECL Kit (ECL, 29050, Engreen) and exposed to X-ray films in a dark room.
Then the membranes were stripped by a stripping buffer (#66-11501, SinoGene Scien-
tific) and reprobed with ß-actin (M20010, Ab-mart). The level of actin was measured
as an internal control.Real-time PCR analysis
Total RNA was isolated from samples using an SG TriEx HiPure RNA Extraction Kit
(#55-11120, SinoGene Scientific, China). RNA concentration was measured at 260 nm
and its purity was assessed with Biophotometer (Eppendorf, Germany) at a ratio of
260:280 nm. RNA samples were treated with DNaseI (EN0523, Fermentas) to remove
contaminating genomic DNA and analyzed on 1.5% agarose gels. Reverse transcription
was performed with a Thermo First cDNA Synthesis Kit (#33-20102, SinoGene Scien-
tific China) with random hexamer primers. The average amount of RNA used in the re-
verse transcription reaction was 1 μg and its purity was around 2.0 (260:280 nm ratio).
qPCR per tube contained 10 μl of 2 × SG Green qPCR Mix (with ROX), (#22-10102,
SinoGene Scientific, China), 250 nM of each primer (List of primers as Table 1), PCR grade
water and 1 μl of cDNA template (diluted in a 1:2 or 1:10 ratio). All samples were assayed
in duplicates with each run. The PCR cycling program consisted of 10 min at 95°C, followedTable 1 Chain reaction primers used for detection in this study
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58°C or 55°C for 30 s and 95°C for 15 s) for dissociation curve analysis. Data were ana-
lyzed by 2-deltadelta Ct method; a statistical comparison between samples was performed
using unpaired Student’s t-test. A p value of <0.05 was considered statistically significant.Ethics statement
All experiments involving the use of animals were incompliance with Provisions and
General Recommendation of Chinese Experimental Animals Administration Legislation
and were approved by Beijing Municipal Science & Technology Commission (Permit
Number: SCXK (Beijing) 2006-0008and SYXK (Beijing) 2006-0025).Statistical analysis
Data is given as means ± S.E.M. for statistical comparison, t-test or one-way ANOVA
followed by Tukey’s test was used.*p < 0.05, **p < 0.01 and ***p < 0.001 were considered
to be statistically significant.Results
XRD measurement
The XRD pattern of DBB is shown in Figure 1. The XRD patterns of the DBB samples
(Figure 1) are very similar to that of pure HA and TCP, and are in accordance with
ASTM data (Card 84–1998 and 70–2005). All of the diffraction peaks were sharp and
well resolved, indicating the two obtained phases.SEM of CMs
The microspheres were spherical and had a regular surface (Figure 2). The particle size
distribution was in the range of 9.634 μm, based on SEM observations. In this study,
the vanillin concentration is crucial to the morphology of the microspheres. To prepare
spherical microspheres with smooth surfaces, the vanillin concentration should be 1%
so assist with crosslinking the CS molecules.Figure 1 XRD pattern of DBB.
Figure 2 SEM of CMs (a: 1.25 μg/ml BMP-2; b: 1 μg/ml BMP-2; c: 0.75 μg/ml BMP-2).
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lyzed. Figure 3a presents a surface image of DBB showing a densely porous structure
with good interconnectivity between the pores. After loading the CMs, the DBB/CMs/
BMP-2 scaffold presented smaller pores with reduced tunnel sizes for interconnectivity
(shown in Figure 3b) than that of the pure DBB scaffold. It also demonstrated that DBB
succeed loading the CMs. The pore size of the DBB scaffold was focused in the range
from 300 to 400 mm. However, as depicted in Figure 3b, the pore size of the DBB/
CMs/BMP-2 scaffold had a wider range from 80 to 300 mm. This greater pore size dis-
tribution could affect cell-proliferation. The stability of the microspheres on the surface
of DBB scaffold was shown in Figure 3c,d, respectively. SEM revealed the microspheres
bonded with DBB by plasma modified. These immobilized microspheres help the re-
lease profile from microspheres immobilized on DBB scaffold surfaces.FT-IR analysis
IR spectra of synthesized DBB, pure CS, and DBB/CMs/BMP-2 composite powders are
shown in Figure 4a,b and c. The major DBB bonds, which are associated with PO4
3−
(1035, 963 and 604 cm−1) and OH− (3571 cm−1), are apparent in Figure 4c. IR spectra
show that there were some changes in the frequencies of PO4
3− and OH−, which shiftFigure 3 SEM of DBB (a: amplified × 400) and DBB/CM/BMP-2 composite scaffold (b: amplified × 600;
c: amplified × 4000; d: amplified × 15000).
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2− (1422 and
1484 cm−1) and HPO4
− (871 cm−1) also appear in the spectra (Figure 4a and d). These
ions also show up in natural bone apatite, called non-stoichiometric apatite.
In Figure 4b, the characteristic peaks of pure CS are displayed at 1655 cm−1, which
can be assigned to the absorption of amide I carbonyl stretching, while the peak of car-
bonyl stretching shifted to 1643 cm−1 in Figure 4c. This change signifies interaction be-
tween CS and DBB.Release testing
Figure 5 shows the in vitro release profiles of encapsulated BMP-2 from CS micro-
spheres loaded on the DBB scaffold. An early burst of approximately 19% of the total
BMP-2 can be seen after being loaded for 24 h, followed by a sustained release of the
remaining BMP-2 over the next 7 days. The experimental data curve indicates that the
BMP-2 release behavior might be attributed to both a reaction-controlled mechanism
and diffusion-controlled mechanism. Thus, this synthesized DBB/CMs/BMP-2 system
would allow for intercelluar release of the drug with high local concentrations at the
site of interest.Attachment and proliferation of cells on DBB/CMs/BMP-2 scaffold
SEM images displaying the morphological features of pre-osteoblastic cells MC3T3-E1
cultured on the bone particles for 24 h are shown in Figure 6. The cells were observed to
spread well and had intimate contact with the inner surface of the scaffold (Figure 6a).
Upon examining the scaffolds at an increased depth, the cells could be seen to adhere
tightly to the crystalline structure of the bone, with aggregated cells being clustered along
the pore walls of the scaffolds (Figure 6b).
A CCK-8 assay was used to evaluate the cytotoxicity of the CMs- scaffold, and the
OD values can provide an indication of cell growth and proliferation on various mate-
rials. As seen in Figure 7, the OD values for the BMP-2 scaffold increased with culture
duration, which indicates that this particular scaffold had no detrimental effect on theFigure 4 FT-IR of CMs (a: DBB; b: CS; c: DBB/CMs/BMP-2 composite).
Figure 5 Release profile for BMP-2 from DBB/CMs/BMP-2 scaffolds in PBS within 7 days.
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ity. In addition, this trend suggested that increasing BMP-2 concentration promote cell
proliferation in these 7 days.Differentiation of cells on CMs- scaffold
Histochemical analyses revealed strong osteogenic properties for the BMP-2 containing
CM scaffold. In order to further confirm the differentiation of MC3T3-E1 cells, the ex-
pression of ALP, BMP-2, OCN and RUNX2 was analyzed at the 3rd day and the 7th day
after culturing on induced medium by western blot (Figure 8). Inductions of osteoblast
specific genes ALP, BMP-2, OCN, and RUNX2 were examined by RT-PCR (Figure 9). The
results of qPCR were consistent with the WB analysis, which showed that the expressions
of OCN, ALP and BMP-2 were increased in contrast with the CON group. The fold-
change of gene expression in the BMP-2 treatment data is shown in Table 2.
Osteoblast cells were noted to proliferate on the materials on day 7 of culture; and
the osteoblasts in the DBB/CMs scaffold without BMP-2 showed a lower increase on
the 7th day of culture compared with those cultured on the other days. In contrast,
cells growing on the DBB/CMs/BMP-2 scaffold did not show an increased tendency for
proliferation at the same time point either with BMP-2. According to the data of the
proliferation assay, the osteoblast cells in the DBB/CMs/BMP-2 scaffold had higher
proliferation rates within 7 days than the controls, which indicated that the BMP-2 pro-
moted cell proliferation. The osteoblast cells in this novel drug delivery system reached
the end of first period faster than the control, which implied that the applied BMP-2
was beneficial to the osteoblast cells’ differentiation as well. Hence, Figure 9 not only
shows the tendency for osteoblast proliferation induced by the drug delivery scaffold
with or without BMP-2, but also indirectly reflects osteoblast differentiation.Discussion
The main objective of this study was to investigate BMP-2/CMs scaffolds as potential
dual-drug/protein delivery systems for slow and sustained delivery of different bioactive
Figure 6 SEM of cell growth on the material surface (a: control without BMP-2; b: DBB/CMs/BMP-2 scaffold).
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lease of bioactive agents can be achieved in vitro using a BMP-2/CMs scaffold. More-
over, the DBB/CMs scaffold loaded with BMP-2 showed excellent osteoinductivity.
In designing a matrix for differentiation factor release, it is apparent that the ex-
tremes of release (bolus injections or prolonged low level release) are not beneficial to
Figure 7 The proliferation of cells on CMs- scaffold with BMP-2.
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require different kinetics of release for optimal performance. For example, in more fluid
environments or compromised (avascular) sites, BMP clearance might be faster than
the bone-induction response of the host. In these cases a slow-release system may be
required. It has been suggested that bone repair therapy is influenced not just by the
amount of protein present but also by the duration of protein production. So an im-
portant issue when accessing growth factors for local bone repair is to identify an ideal
drug delivery carrier which can ensure a sufficient protein concentration and effect at
the application site for the duration of the healing process, and therefore provide an ap-
propriate support for bone repair. In the current study, the BMP-2 release resulted in a
gradual, sustained protein release pattern. Further investigations are needed to analyze
the in vivo release of BMP-2.
The degradability of CaP-based materials is very important for the in vivo longevity
and efficacy of its biological effects. The findings of this study indicate that CMs scaf-
folds are degradable and both in vitro and in vivo results indicate that the coating canFigure 8 On the 3rd day, the expression levels of OCN and ALP were increased and RUNX2 was decreased
in contrast with the control group, while the expression of BMP-2 had no significant difference between
the two groups. On the 7th day, the expressions of ALP, OCN, BMP2 had increased and the expression of
RUNX2 had decreased in both the control and BMP-2 group compared with their expression status on the
third day.
Figure 9 Compared the control group, on the 3rd day and the 7th of treatment, expression levels of genes
OCN, BMP-2 and ALP increased (p < 0.05). RUNX2 genes were observed to decrease.
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biodegradable.
The coating and Bio-CaP were all biomimetically formed by precipitation of calcium
phosphate. However, their surface structures were totally different before coating. It
was demonstrated that BMP-2 incorporated into biomimetic coatings can retain its bio-
logical activity and that the growth factors released through osteoclastic activity could
significantly promote osteoblastogenesis in vitro. Therefore, we assume that BMP-2
maintains its activity. However, further investigations are needed to prove the specific
activity of BMP-2.
In bone tissue engineering, osteoblast cells are one of the most crucial factors that
lead to the ultimate formation of new bone tissue. The ECM proteins function as a
substratum for bone cell adhesion and serve as a scaffold for mineralization [18]. In the
current work, the constructs of the CMs scaffold drug delivery system of DBB/CMs/
BMP-2 were observed with SEM after culturing with an osteogenesis-inducing medium
for 7 days (Figure 6). In general, cells growing on the DBB/CMs scaffold revealed many
typical globular round cells which integrated with the scaffold. In particular, the DBB/
CMs/BMP-2 group showed that the cells growing on this material were surrounded by
a thick substance. The reason is that the BMP-2 produced many substances on the sur-
face of the original scaffold, which assisted the osteoblasts growth. Besides, BMP-2 also
assisted the proliferation tendency of the osteoblasts induced by the drug delivery scaf-
fold (Figures 8 and 9).
Table 2 Fold-change of different gene expressions after BMP-2 treatment
Day3 CON Day3 Trt Day 7 CON Day 7 Trt
ALP 1 ± 0.1716 4.637 ± 0.3565*** 1.003 ± 0.4517 5.077 ± 0.08647***
BMP-2 1 ± 0.08 2.64 ± 0.13** 1 ± 0.2894 7.483 ± 1.058**
OCN 1.003 ± 0.2128 1.823 ± 0.3724* 1 ± 0.1856 25.94 ± 4.835**
RUNX2 0.9967 ± 0.1073 0.87 ± 0.1626 1 ± 0.2649 0.2404 ± 0.02242
***P < 0.001, **P < 0.01, *P < 0.05.
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tein delivery vehicle. In addition, the use of the coating can offer an alternative for slow
release. CMs scaffolds can offer a dual-release system for a sequential delivery of differ-
ent proteins/drugs. This combination could be applicable for a variety of clinical appli-
cations. For example, osteogenic agents can be incorporated into the interior of CMs
scaffolds, and at the same time, antibiotics can be incorporated into the surface coating.
This could be considered as a new strategy for the treatment of bone defects caused by
peri-implantitis. In conclusion, it was shown that the CMs scaffold with an internal or
surface-coated depot of protein has the capacity to maintain a slow and sustained pro-
tein release in the presence of osteoclasts in vitro. Further investigations are needed to
prove the in vivo release and actual activity of BMP-2. The dual-drug release system of-
fers a promising tool for the controlled delivery of multiple therapeutic agents, such as
antibiotics, osteogenic agents, and anti-cancer drugs for different clinical applications.Conclusions
A functional scaffold loading microspheres system was successfully developed and
shown to be an excellent drug delivery platform for bone regeneration. BMP-2 as a
model bioactive molecule was efficiently added to the microsphere-loading DBB scaf-
fold with perfect biocompatibility, and offered efficient release kinetics of BMP-2.
Therefore, this novel CS microsphere-loaded DBB scaffold system may be applicable as
a promising scaffold for bone regeneration.
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